甲基丙二酸血症肾脏管理临床实践建议:ERKNet与MetabERN专家共识声明
该共识由欧洲罕见肾病参考网络与欧洲遗传代谢病参考网络联合制定,涵盖儿童和成人肾脏病、代谢及移植专家,针对甲基丙二酸血症的慢性肾病、透析和移植管理提出13条建议。共识指出基于肌酐的公式显著高估肾功能,胱抑素C估算的估算肾小球滤过率更准确;急性代谢失代偿时需急诊透析清除代谢毒素,长期透析需长时血液透析和/或每日透析;移植指征包括高代谢失代偿率、高疾病负担和代谢控制困难,合并慢性肾病者优先考虑肝肾联合移植,并需监测钙调神经磷酸酶抑制剂神经毒性。
要点
- 基于肌酐的公式显著高估甲基丙二酸血症患者肾功能,胱抑素C估算的估算肾小球滤过率更准确。
- 急性代谢失代偿时,除常规肾脏指征外,需急诊透析清除代谢毒素。
- 长期透析用于清除毒性代谢产物,需长时血液透析和/或每日透析。
- 移植指征为高代谢失代偿率、高疾病负担和代谢控制困难,以及长期并发症。
- 合并慢性肾病的甲基丙二酸血症患者优先考虑肝肾联合移植,免疫抑制治疗中需监测和调整钙调神经磷酸酶抑制剂神经毒性。
适用人群与场景
- 儿童和成人甲基丙二酸血症患者,需在儿科和成人科室进行慢性肾病专项随访。
诊断标准与关键阈值
- 基于肌酐的公式显著高估肾功能,估算估算肾小球滤过率应使用胱抑素C更准确。
- 移植指征:高代谢失代偿率、高疾病负担、代谢控制困难,或出现长期并发症。
处置流程与药物剂量
- 急性代谢失代偿时,除常规肾脏指征外,需急诊透析清除代谢毒素。
- 长期透析用于清除毒性代谢产物,需长时血液透析和/或每日透析。
- 合并慢性肾病的甲基丙二酸血症患者优先考虑肝肾联合移植。
- 使用钙调神经磷酸酶抑制剂时需监测和调整免疫抑制治疗,因可能发生神经毒性。
研究设计与关键结果
- 该共识由欧洲罕见肾病参考网络与欧洲遗传代谢病参考网络联合制定,涵盖儿童和成人肾脏病专家、代谢专家及肝移植和肾移植专家,共产生13条建议,指导甲基丙二酸血症儿童和成人患者的慢性肾病、透析和移植管理。
证据类型、等级与局限
- 证据类型:专家共识;局限:原文未报告局限性。
对床旁实践的改变
- 甲基丙二酸血症患者随访应使用胱抑素C估算估算肾小球滤过率,避免基于肌酐的公式高估肾功能。
- 急性代谢失代偿时需考虑急诊透析清除代谢毒素。
- 长期透析需安排长时血液透析和/或每日透析。
- 合并慢性肾病者优先选择肝肾联合移植;使用钙调神经磷酸酶抑制剂时需监测神经毒性并调整治疗。
指南或共识出处
- 甲基丙二酸血症肾脏管理临床实践建议:欧洲罕见肾病参考网络与欧洲遗传代谢病参考网络专家共识声明(Kidney Int Rep)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Methylmalonic acidemias (MMAs) are rare inherited metabolic diseases with multiorgan involvement. Chronic kidney disease (CKD) is a common complication, leading to kidney failure, dialysis, and kidney transplantation (KT). The objective of these guidelines was to develop clinical practice recommendations focusing on specific aspects of the kidney management of this disease. Development of these clinical practice recommendations is an initiative of the European Reference Network for Rare Kidney Diseases in collaboration with the European Reference Network for Hereditary Metabolic Disorders and included pediatric and adult nephrologists, metabolic specialists, as well as liver and kidney transplant specialists. CKD has become a significant clinical issue that requires specific follow-up in both pediatric and adult departments. Creatinine-based formulae significantly overestimate kidney function and the estimation of estimated glomerular filtration rate (eGFR) is more accurate using cystatin C. Besides usual kidney indications, acute dialysis may be required in emergency in case of acute metabolic decompensation to clear metabolic toxins. Long-term dialysis may be initiated for clearance of toxic metabolites. Long hours on hemodialysis (HD) and/or daily dialysis are required. The indications for transplantation in MMA are a high rate of metabolic decompensations, a high burden of disease and difficult metabolic control. Transplantation is also indicated in case of long-term complications. Combined liver-kidney transplantation (LKT) should be preferred in patients with MMA with CKD. Possible calcineurin inhibitors (CNIs) induced neurotoxicity was described in patients with MMA requiring immunosuppressive treatment monitoring and adaptation. Overall, 13 statements were produced to provide guidance on the management of CKD, dialysis, and transplantation in pediatric and adult patients with MMA.
参考来源
- Servais A, Zacchia M, Dehoux L, et al. Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN. Kidney Int Rep. 2024. PMID: 39698355. doi:10.1016/j.ekir.2024.09.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。